Pharmacologic treatment of anxiety disorders in 1989 versus 1996: Results from the Harvard/Brown Anxiety Disorders Research Program

Journal of Clinical Psychiatry

Volumn 62, Issue 3, 2001, Pages 149-152

  Salzman, C ^a   Goldenberg, I ^a   Bruce, S E ^a   Keller, M B ^a  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; PAROXETINE; VENLAFAXINE;

ADULT; AGORAPHOBIA; ANXIETY NEUROSIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; PANIC; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0035063513     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0302     Document Type: Article

References (30)

1. Benzodiazepine treatment of panic and agoraphobic symptoms: Use, dependence, toxicity, abuse
2. The pharmacotherapy of acute anxiety: A miniupdate
3. Issues in the long-term treatment of anxiety disorders
4. Maintenance drug treatment for panic disorder, 1: Results of a prospective, placebo-controlled comparison of alprazolam and imipramine
5. Maintenance drug treatment for panic disorder, 2: Short- and long-term outcome after drug taper
6. Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties
7. Antidepressants in panic disorder: Clinical and preclinical mechanisms
8. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial, 1: Efficacy in short-term treatment
9. Serotonin function in panic disorder: A double-blind, placebo-controlled study with fluvoxamine and ritanserin
10. Double-blind comparison of sertraline and placebo in patients with panic disorder
11. Double-blind pilot trial of desipramine versus fluoxetine in panic patients
12. Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone and diazepam
13. Comorbidity of anxiety disorders in a multicenter anxiety study
14. The infrequency of "pure culture" diagnoses among the anxiety disorders
15. Comorbidity among anxiety disorders: Implications for treatment and DSM-IV
16. Generalized anxiety disorder vs panic disorder: Distinguishing characteristics and patterns of comorbidity
17. Quality of life and psychiatric morbidity in panic disorder versus generalized anxiety disorder
18. Diagnostic criteria for use in psychiatric research
19. Benzodiazepines: Use, abuse, and consequences
20. The use of minor tranquilizers and antidepressants by depressed outpatients: Results from the Medical Outcomes Study
21. The adequacy of treating depression
22. Undertreatment of major depression
23. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients
24. A comparison of adequately vs inadequately treated depressed patients
25. The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression
26. Pharmacotherapy of panic disorder: Differential efficacy from a clinical viewpoint